Type | Investment In | % of NAV | No. of shares | Value (Rs cr) |
Domestic Equities | Sun Pharmaceutical Industries Ltd. | 13.9771 | 2800000 | 513.0440 |
Domestic Equities | Divi's Laboratories Ltd. | 6.6332 | 400000 | 243.4800 |
Domestic Equities | Max Healthcare Institute Ltd. | 6.2829 | 2100000 | 230.6220 |
Domestic Equities | Cipla Ltd. | 5.0676 | 1200000 | 186.0120 |
Domestic Equities | Lupin Ltd. | 4.7957 | 840000 | 176.0304 |
Domestic Equities | Polymedicure Ltd. | 3.7867 | 540000 | 138.9960 |
Domestic Equities | Mankind Pharma Ltd. | 3.7611 | 560000 | 138.0568 |
Domestic Equities | Krishna Institute of Medical Sciences Ltd. | 3.6405 | 2034372 | 133.6277 |
Domestic Equities | Jupiter Life Line Hospitals Ltd. | 3.1986 | 800000 | 117.4080 |
Domestic Equities | Fortis Healthcare Ltd. | 3.1377 | 1680000 | 115.1724 |
Domestic Equities | Ami Organics Ltd. | 3.0801 | 1000000 | 113.0600 |
Domestic Equities | Aether Industries Ltd. | 3.0717 | 1400000 | 112.7490 |
Domestic Equities | Abbott India Ltd. | 2.9408 | 36000 | 107.9460 |
Domestic Equities | Aster DM Healthcare Ltd. | 2.8889 | 2100000 | 106.0395 |
Domestic Equities | Alkem Laboratories Ltd. | 2.7875 | 200000 | 102.3200 |
Domestic Equities | Torrent Pharmaceuticals Ltd. | 2.7151 | 300000 | 99.6600 |
Domestic Equities | Aurobindo Pharma Ltd. | 2.6788 | 800000 | 98.3280 |
Domestic Equities | Laurus Labs Ltd. | 2.4676 | 1500000 | 90.5775 |
Domestic Equities | Rainbow Children's Medicare Ltd. | 2.4091 | 640000 | 88.4288 |
Domestic Equities | Gland Pharma Ltd. | 2.0596 | 540000 | 75.6000 |
Domestic Equities | Biocon Ltd. | 1.7534 | 2000000 | 64.3600 |
Domestic Equities | Suven Pharmaceuticals Ltd. | 1.6728 | 540000 | 61.4034 |
Domestic Equities | Concord Biotech Ltd. | 1.6549 | 400000 | 60.7440 |
Domestic Equities | Vijaya Diagnostic Centre Ltd. | 1.6354 | 600000 | 60.0300 |
Domestic Equities | Pfizer Ltd. | 1.1695 | 100000 | 42.9280 |
Domestic Equities | Akums Drugs & Pharmaceuticals Ltd. | 1.1506 | 808746 | 42.2327 |
Domestic Equities | Sanofi Consumer Healthcare India Ltd. | 1.0094 | 75000 | 37.0500 |
Domestic Equities | Gufic Biosciences Ltd. | 1.0017 | 1000000 | 36.7700 |
Total | | 92.4280 | | 3392.6762 |
Cash & Cash Equivalents and Net Assets | TREPS | 1.7321 | | 63.5780 |
Cash & Cash Equivalents and Net Assets | Net Receivable / Payable | 0.7912 | | 29.0408 |
Total | | 2.5232 | | 92.6188 |
Treasury Bills | 182 DAY T-BILL 05.06.25 | 0.0813 | 300000 | 2.9832 |
Total | | 0.0813 | | 2.9832 |
Overseas Equities | Lonza Group | 4.9675 | 300000 | 182.3377 |
Total | | 4.9675 | | 182.3377 |